Report Urges G7 Countries to Commit to Incentives for Antibiotic Development

The Global Coalition on Aging (GCOA) last week issued a report calling on G7 countries to commit to funding pull incentives and making other investments in antibiotic innovation.

The report, which summarizes a GCOA-convened April meeting that included experts and government officials from Japan, the United States, Canada, the United Kingdom, Italy, and the European Union, asserts that the lack of new antibiotics and rising resistance to current antibiotics is having a severe impact on those most at risk of infection and that the current antibiotic pipeline is inadequate and must be prioritized.

Therefore, the experts concluded, incentive structures to develop new antibiotics, such as the subscription-based model adopted in the United Kingdom, must be supported, and other countries in the G7 must “rise to the challenge” and complement the UK model with their own incentives. To date, the United Kingdom is the only country to follow up on pledges to incentivize new antibiotic research and development made at the 2022 G7 meeting.

Call for ‘fair share’ contributions

Noting that the current healthcare burden of antimicrobial resistance (AMR) is estimated at $1 trillion globally, the experts agreed that if all G7 countries contributed their “fair share” to a $4.5 billion pull incentive to fund a single new antibiotic, the return on investment would be 5:1.

The report urged G7 countries to use the opportunity presented by the upcoming United Nations High-Level Meeting on AMR and demonstrate their commitment to solving the problem.

“There will never be more political momentum on AMR than this year,” the report states. “All countries must take this opportunity to address AMR through collaborative multi-stakeholder action and commitments to invest a fair share in our most vital healthcare infrastructure.”

Source: University of Minnesota, CIDRAP

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.

New Report From the Global Coalition on Aging Highlights the Connection Between Adult Immunization and Economic Health in Aging APEC Region

As leaders from across the Asia-Pacific Economic Cooperation (APEC) region convene in San Francisco over the next week, a new report from the Global Coalition on Aging (GCOA) points to investments in healthy aging as a growing economic imperative amid the region’s changing demographics. According to the new report, programs that keep populations healthy, active, and productive – like adult immunization – are increasingly becoming a prerequisite for economic stability and growth.

Menopause, the Silver Economy and Workplace Opportunities

As we recognise World Menopause Day, take a moment to consider the economic power, diverse expertise and skills, and incredible societal contributions of the estimated 1.1 billion post-menopausal women worldwide by 2025—a population on-par with China or India, and dwarfing any other country. Indeed, if we want to fuel the vibrant $15 trillion silver economy, societies, governments, and employers must empower older women in the future of work, including solutions that fight stigma and increase workplace support related to menopause.